BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 15, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

AX200: Completed Phase II enrollment

Sygnis completed enrollment of 328 patients who had an ischemic stroke within 9 hours in the double-blind, placebo-controlled, European Phase II AXIS 2 trial evaluating a 3-day continuous IV infusion of...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >